These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. FDA initiative will enhance drug good manufacturing practices. FDA Consum; 2002; 36(6):4. PubMed ID: 12523283 [No Abstract] [Full Text] [Related]
5. PDA response. FDA advance notice of proposed rulemaking on electronic identification/signatures. Parenteral Drug Association. J Parenter Sci Technol; 1993; 47(1):4-8. PubMed ID: 8445499 [No Abstract] [Full Text] [Related]
6. Quality control and good manufacturing practices: safety and efficacy of commercial herbals. Awang DV. Food Drug Law J; 1997; 52(3):341-4. PubMed ID: 10343036 [No Abstract] [Full Text] [Related]
7. PDA presentation at FDA Open Conference on Sterile Drug Manufacturing. Parenteral Drug Association. J Pharm Sci Technol; 1994; 48(1):4-6. PubMed ID: 8004417 [No Abstract] [Full Text] [Related]
8. Current good manufacturing practice in manufacturing, packaging, labeling, or holding operations for dietary supplements. Final rule. Food and Drug Administration, HHS. Fed Regist; 2007 Jun 25; 72(121):34751-958. PubMed ID: 17674484 [Abstract] [Full Text] [Related]
9. Application of ISO 9002 and FDA's good manufacturing practices to general chemical manufacturing. Kauffman JM, Weiler ED. Qual Assur; 1992 Jun 25; 1(3):213-6. PubMed ID: 1344676 [Abstract] [Full Text] [Related]